Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer
Background: The optimal sequencing of regorafenib and trifluridine/tipiracil (FTD/TPI) in refractory metastatic colorectal cancer (mCRC) remains uncertain, particularly in Asian populations. Methods: We retrospectively analyzed 110 patients with mCRC who sequentially received both agents between 201...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI AG
2026-03-01
|
| Серии: | Life |
| Предметы: | |
| Online-ссылка: | https://www.mdpi.com/2075-1729/16/4/564 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|